Peptides and chemical compound for inhibition of SHP2 function
AssigneeWest Virginia University
InventorsYehenew Mekonnen Agazie, Peter M. Mannett
Life of this patent
Estimating the term…
Abstract
The present invention relates to the inhibition of the function of SHP2 by both anti-SHP2 peptides and the chemical compound 4-(2-sulfaminoethyl)benzoic acid, SEBA, and SEBA derivatives binding to the phosphotyrosyl phosphatase domain of SHP2 thereby inhibiting the function of SHP2 both in vitro and in vivo. In addition, the inhibition of SHP2 may be useful as a treatment for human disease, and it has been shown that interfering with SHP2 function using the anti-SHP2 peptides and SEBA compounds reverses cell transformation and induces remission of preformed tumors in vivo demonstrating a possible treatment for cancer.
Claims7
An anti-SHP2 peptide consisting of a purified amino acid sequence selected from the group consisting of SEQ ID NO:
- 1;
- SEQ ID NO:
- 2;
- SEQ ID NO:
- 3;
- SEQ ID NO:
- 4;
- and SEQ ID NO:
- 5 or a conservative variant thereof wherein said conservative variant is Glu for Asp at −4, Asp for Glu at −4, Val for Gly at −2 and Gly for Val at −2 wherein said peptide is able to inhibit SHP2 without binding the SH2 domain.
An isolated peptide consisting of a Tyr residue as a substrate, a Asp residue at the −2 position, hydrophobic residues at the −1 and −3 positions and either an Asp or a Glu residue at the −4 position wherein the peptide is able to block the phosphatase domain of SHP2 without binding SH2 and wherein the peptide consists of 5 residues.
Dependencies are inferred from the claim text.